Latest News

After COVID-19 infection, antibodies highly protective for months, prospective study shows


 

Real-life implications

“There is no such thing as 100% protection, even from the infection itself. So when you’re dealing with someone with possible exposure to COVID-19, you still need to follow the proper precautions,” Dr. Slifka said.

Nonetheless, he said, “This is great news for those on the front lines who are wondering whether or not they would have any protection if they had COVID-19 before. And the answer is yes – there is a very good chance they will have protection, based on this quite large study.”

One limitation of the study is that the population consisted predominantly of healthy adult health care workers aged 65 years or younger. “Further studies are needed to assess postinfection immunity in other populations, including children, older adults, and persons with coexisting conditions, including immunosuppression,” the researchers noted.

Dr. Eyre plans to continue following the health care workers in the study, some of whom have been vaccinated for COVID-19. This ongoing research will allow him and coinvestigators to “confirm the protection offered by vaccination and investigate how postvaccine antibody responses vary by whether you have had COVID-19 before or not. We also want to understand more about how long postinfection immunity lasts.”

Dr. Eyre has received grants as a Robinson Foundation Fellow and NIHR Oxford BRC senior fellow during the conduct of the study. Dr. Slifka and Dr. King report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

New coalition demands urgent action on COVID-19 mental health crisis
MDedge Family Medicine
COVID-19 variant sparks U.K. travel restrictions
MDedge Family Medicine
Give psych patients the COVID vaccination now, experts say
MDedge Family Medicine
Doctors publish paper on COVID-19 protocol; Experts unconvinced
MDedge Family Medicine
Latest rise in child COVID-19 cases is relatively small
MDedge Family Medicine
COVID-19 anticoagulation trials ‘paused’ for futility, safety
MDedge Family Medicine
Call to arms: vaccinating the health workforce of 21 million strong
MDedge Family Medicine
Child abuse visits to EDs declined in 2020, but not admissions
MDedge Family Medicine
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
MDedge Family Medicine
Pregnant women should be offered COVID-19 vaccine, experts agree
MDedge Family Medicine